nivolumab,brentuximab,doxorubicin hydrochloride,dacarbazine,filgrastim,pegfilgrastim,vinblastine sulfate
seagen,amgen,bms
['hodgkin', 'lymphoma', 'so proud', 'nivo']
have been looking forward to seeing this data highlighted at the #asco23 plenary - important new practice changing data for frontline hodgkin s lymphoma for nivo-avd! and so proud to see mentor-extraordinaire on the author list! 
Heme/Onc fellow @UCCancerCenter interested in aggressive lymphoma, novel therapeutics, and cellular therapies #lymsm #TcellRx. Views are my own.